Multiple Sclerosis News

News

Multiple Sclerosis (MS) May Be Caused by the Epstein Barr Virus | PRLog
www.prlog.org | Jan 13, 2012
Multiple Sclerosis (MS) May Be Caused by the Epstein Barr Virus. The cause of Multiple Sclerosis (MS) may be the Epstein Barr Virus (EBV). This is according to a new study published in the scientific journal, “Neurology.” - PR11771350

The Boston Home Unveils $150,000 Renovation of Pavilion for Day Program Serving Community Members
www.prweb.com | Nov 11, 2011
Revamped Space for Program Supported by Gifts from the Yawkey Foundation, Citizens Bank, Biogen Idec, Carney Hospital, Milton Hospital, Fallon Ambulance, and Individual Donors

Genzyme Corporation Appoints Leaders for Multiple
www.biospace.com | Nov 10, 2011
CAMBRIDGE, Mass.---- Genzyme, a Sanofi company , announced today the appointment of William “Bill” Sibold as Head of Multiple Sclerosis and Rogério

3 Undervalued Biotechs With Buyout Potential - Seeking Alpha
seekingalpha.com | Aug 3, 2011
< strong > By < a href='http://seekingalpha.com/author/rougemont' > Rougemont < /a > : < /strong > here. < br/ > < a href='http://seekingalpha.com/article/284119-3-undervalued-biotechs-with-buyout-potential?source=feed' > Complete Story & raquo; < /a > < div class="feedflare" > < a

Medical News: CMSC: MiRNAs Dubbed Biomarkers, Tx Targets in MS - in Meeting Coverage, CMSC from
www.medpagetoday.com | Jun 4, 2011
MONTREAL -- Several short, noncoding RNA molecules are associated with multiple sclerosis symptoms, perhaps in enough of a causal way to become therapeutic targets as well as biomarkers of disease, a

Scientists develop compound that effectively halts progression of multiple sclerosis
www.eurekalert.org | Apr 20, 2011
Scientists from the Florida campus of the Scripps Research Institute have developed the first of a new class of highly selective compounds that effectively suppresses the severity of multiple sclerosis in animal models. The new compound could provide new and potentially more effective therapeutic

Scottish scientists open new front in battle against MS - Scotsman.com News
news.scotsman.com | Dec 6, 2010
Scottish scientists open new front in battle against MS - SCOTTISH scientists have made a "revolutionary" breakthrough which could reverse damage caused by multiple sclerosis (MS).<br />

Gilenya changes multiple sclerosis landscape | Pharma Asia
www.pharmaasia.com | Oct 4, 2010
Gilenya is set to become the leading treatment in multiple sclerosis (MS) with multi-blockbuster sales, ending the decade long dominance of interferon betas and Copaxone (glatiramer acetate, Teva), says Trung Huynh, healthcare analyst, Datamonitor. The US FDA approved Novartis’s Gilenya (formally

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis : The
www.thelancet.com | Aug 16, 2010
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. By - Dr Axel Petzold MD, Prof Johannes F de Boer PhD, Sven Schippling MD, Prof Patrik Vermersch MD, Prof R...

Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab
www.abbott.com | May 24, 2010
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapsing-Remitting Multiple Sclerosis